Patent · US Active

Defibrotide for use in prophylaxis and/or treatment of Graft versus Host Disease (GVHD)

US8980862B2 · kind B2 · utility

7Cited by

24References

14Claims

0Family size

Assignee

Gentium S.p.A. · IT

Inventor

Massimo Iacobelli · Milano, IT

Key dates

Filing date	Nov 12, 2010
Grant date	Mar 17, 2015
Priority date	—
Expiry date	Dec 19, 2030

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC12N15/111
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

Defibrotide for use in prophylaxis and/or treatment of Graft versus Host Disease (GVHD) in humans is disclosed, preferably in hematopoietic stem cell transplantation (HSCT), more preferably allogeneic hematopoietic stem cell transplantation. Graft versus Host Disease of the invention (GVHD) can be acute aGVHD and/or chronic cGVHD, preferably acute.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.